Latest Feature

Kimberly-Clark readies Halyard Health medical device spinout

Halyard Health, the publicly traded, $1.6 billion spinout of Kimberly-Clark's medical device business, is slated to go live in November, soon-to-be COO Chris Lowery tells MassDevice.com.

HART CEO David Green on the transformative potential for regenerative medicine

David Green tells MassDevice.com about the decision to split Harvard Bioscience and Harvard Apparatus Regenerative Technology, his choice to move over to the new entity and why regenerative technologies are poised to transform medicine.

Wound care by the numbers: Q&A with Alliqua CEO Dave Johnson

Medtech veteran Dave Johnson has been with Alliqua Biomedical for less than 2 years, during which time he's overseen a major hiring spree, 3 business development deals and the company's 1st acquisition. In an interview with MassDevice.com, Johnson talks about his step-by-step perspective and where he hopes Alliqua will be in 5 years.

Podcast: Medtech legends and leaders on the state of medical device innovation

MassDevice.com brought together 4 of the most influential leaders in medtech to discuss the future of the industry on July 15, 2014 at DeviceTalks Boston.

CardioMEMS took 11 years to pay off, but for Boston Millennia it was worth it

Boston Millennia's managing general partner Dana Callow discusses the 11-year journey to bring CardioMEMs implantable heart monitor to market and what his venture capital firm sees for the future of medtech investment.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

MassDevice.com +3 | The top 3 medtech stories for September 23, 2014

September 23, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Abbott Vascular to shutter Texas plant, move 50 jobs to California

September 23, 2014 by Alexander Soule

Abbott Vascular plans to shutter a plant in Texas that makes its Supera peripheral stents as it shifts production and 50 jobs to another plant in California.

Abbott Vascular to shutter Texas plant, move 50 jobs to California

Breast implant maker Sientra registers an $86M IPO

September 23, 2014 by Arezu Sarvestani

Medical aesthetics company Sientra files registration documents for an initial public offering proposed to raise as much as $86.3 million.

Breast implants: Sientra registers an $86M IPO

California medical device maker Sientra Inc. is looking to hit the public markets with an initial public offering that could raise as much as $86.3 million, according to an SEC filing.

Ivantis adds $25M, eyes U.S. approval for glaucoma micro-stent

September 23, 2014 by Alexander Soule

Ivantis takes its Series B round to $71 million with another $25 million tranche as it looks to get its Hydrus micro-stent for glaucoma on the U.S. market.

Ivantis adds $25M, eyes U.S. approval for glaucoma micro-stent

Ivantis today said it added a $25 million tranche to its now $71 million Series B round as the Irvine, Calif.-based company looks to bring its miniature glaucoma scaffold to the U.S. market.

AdvaMed, PhRMA, BIO protest Sunshine law

September 23, 2014 by Arezu Sarvestani

A coalition of life sciences lobbying groups bands together to demand more clarity from laws aiming to add transparency to physician-industry relationships.

AdvaMed, PhRMA, BIO protest Sunshine law

Medicare's Sunshine Act database is slated to go public later this month with a year's worth of data on industry relationships with physicians, but an alliance of life sciences groups is calling for some sunshine of its own.

Philips to carve out lighting biz, merger healthcare & consumer units

September 23, 2014 by Alexander Soule

Royal Philips reveals plans to spin out its legacy lighting business and merge Philips Healthcare and its consumer business into a new 'HealthTech' unit.

Philips to carve out lighting biz, merger healthcare & consumer units

BSX wins CE Mark approval for Vercise deep-brain stim device | Regulatory news for the week of September 22, 2014

September 23, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Boston Scientific wins CE Mark for Vercise brain stim device; 20 Years of Improving Women's Health; Medtronic wins CE Mark for Tyrx cardiac device envelope; VertiFlex lands FDA panel date for Superion interspinous spacer

Boston Scientific wins CE Mark for Vercise brain stim device

September 17, 2014 by Brad Perriello

Medtronic, Covidien slide on new U.S. inversion rules

September 23, 2014 by Brad Perriello

New rules on inversion mergers announced yesterday by the U.S. Treasury Dept. send shares of Medtronic and Covidien down as questions swirl about the impact ion their pending $43 billion merger.

Medtronic, Covidien slide on new U.S. inversion rules
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp